Stifel lowered the firm’s price target on Nyxoah (NYXH) to $15 from $16 and keeps a Buy rating on the shares. For the quarter, revenue was “light,” offset by better-than-expected gross margin, but “it is all about U.S. Genio approval and the subsequent ramp,” the analyst tells investors in an earnings recap note.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NYXH: